RECRUITINGOBSERVATIONAL
Biologics for Stricturing Crohn's Diseases
The Clinical Outcomes of Patients With Stricturing Crohn's Diseases Received Biologics: a Prospective, Observative Study
About This Trial
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Who May Be Eligible (Plain English)
Who May Qualify:
- patients with stricturing Crohn's diseases
- no surgical indication
- patients with asymptomatic penetrating diseases
- written consent acquired
Who Should NOT Join This Trial:
- patients with surgical indication
- patients with symptomatic penetrating diseases
- contraindication of biologics
- anticipating other trial
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* patients with stricturing Crohn's diseases
* no surgical indication
* patients with asymptomatic penetrating diseases
* written consent acquired
Exclusion Criteria:
* patients with surgical indication
* patients with symptomatic penetrating diseases
* contraindication of biologics
* anticipating other trial
Treatments Being Tested
OTHER
treat these patients with biologics
treat these patients with biologics
Locations (1)
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
Nanjing, Jiangsu, China